Figure 3From: Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapyKaplan-Meier survival curves according to neutrophil-lymphocyte ratio (NLR) before surgery. (A) Progression-free survival and (B) overall survival. P values were determined using the log-rank test.Back to article page